Description: CannaPharmaRx, Inc. is an early-stage pharmaceutical company whose purpose is to advance cannabinoid research and discovery using proprietary formulation and drug delivery technology currently in development. Cannabinoids are a class of chemicals that, once ingested, are active in humans and animals through the \
Home Page: www.cannapharmarx.com
888 3rd Street SW
Calgary,
AB
T2P 5C5
Canada
Phone:
949 652 6838
Officers
| Name | Title |
|---|---|
| Mr. Dominick Colvin | CEO, Pres & Director |
| Mr. John Hamilton Cassels C.A., CPA | CFO & Sec. |
| Mr. Andrew Clifford Steedman | Chief Operations Officer |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 11.0543 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 4 |